UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM  i 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  i May 14, 2021

 

 i MEDPACE HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

i Delaware		i 001-37856		i 32-0434904
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 i 5375 Medpace Way

 i Cincinnati,  i Ohio  i 45227

(Address of Principal Executive Offices, and Zip Code)

 i (513)  i 579-9911

Registrant’s Telephone Number, Including Area Code

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

i ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

i ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

i ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

i ☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
i Common Stock		i MEDP		i Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 5.07.

Submission of Matters to a Vote of Security Holders.

(a) On May 14, 2021, Medpace Holdings, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders.

(b) Stockholders voted on the matters set forth below.

Proposal 1 — Election of Directors

The following nominees were elected to the Company’s Board of Directors to serve as Class II Directors until the Company’s 2024 Annual Meeting of Stockholders based upon the following votes:

 

		Votes For				Votes Withheld				Broker Non-Votes
Fred B. Davenport, Jr.			13,611,160				18,800,233				828,001
Cornelius P. McCarthy III			20,068,499				12,342,894				828,001

Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm

The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 was ratified based upon the following votes:

 

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
31,816,172		1,408,143		15,079		0

Proposal 3 — Advisory Vote on the Compensation of our Named Executive Officers

The proposal to approve, on an advisory basis, the compensation of the Company’s Named Executive Officers was approved based upon the following votes:

 

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
16,348,309		16,015,301		47,783		828,001

(c) Not applicable.

(d) Not applicable.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

						MEDPACE HOLDINGS, INC.
Date:		May 14, 2021				By:		/s/ Stephen P. Ewald
						Name:		Stephen P. Ewald
						Title:		General Counsel and Corporate Secretary